By Marty Trieschmann

The Breast Cancer Program at the University of Arkansas for Medical Sciences (UAMS) Winthrop P. Rockefeller Cancer Institute has earned reaccreditation from the National Accreditation Program for Breast Centers (NAPBC) for the fourth time in 10 years.

The UAMS Breast Cancer Program first received accreditation from NAPBC in 2014 and was reaccredited in 2017 and 2020. NAPBC is a program of the American College of Surgeons and represents a consortium of national professional organizations dedicated to improving of the quality of care and monitoring of outcomes for patients with diseases of the breast.

“Being recognized again by NAPBC distinguishes the UAMS Breast Cancer Program as one of the leading breast cancer treatment programs in the United States,” said Ronda S. Henry-Tillman, M.D., chief of breast oncology at UAMS and the Muriel Balsam Kohn Chair in Breast Surgical Oncology at UAMS.

UAMS Breast Cancer Program Earns Fourth National Accreditation

By Marty Trieschmann

Researchers at the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS) have been awarded five new grants from the National Cancer Institute (NCI) in 2024, totaling $4.6 million.

New grants include:

$3.3 million NCI grant to create a Melanoma Resistance Evolution Atlas, Principal Investigator: Alan Tackett, Ph.D., Winthrop P. Rockefeller Cancer Institute deputy director
$421,000 NCI grant to study cancer-evolved resistance mechanism to enhance adoptive T-cells, Principal Investigators: Tackett and Brian Koss, Ph.D., UAMS assistant professor of biochemistry and molecular biology
$393,000 NCI grant to study the mechanisms of TH17-DC immunotherapy for ovarian cancer. Principal Investigator: Martin Cannon, Ph.D., UAMS professor of microbiology and immunology
$393,000 NCI grant to study SR-A as a therapeutic target in breast cancer. Principal Investigators: Steven Post, Ph.D., UAMS professor of pathology, and Behjatolah Karbassi, Ph.D., UAMS associate professor of pathology
$153,000 NCI grant to study the development of immunocompetent melanoma brain metastases organoids. Principal Investigator: Analiz Rodriguez, M.D., Ph.D., UAMS associate professor of neurosurgery

UAMS Winthrop P. Rockefeller Cancer Institute Awarded Five New Grants from National Cancer Institute